Your session is about to expire
← Back to Search
HPV Self-Testing Intervention for Cervical Cancer Screening
Study Summary
This trial looks at whether a self-testing intervention for HPV can increase cervical cancer screening rates among women in Appalachia.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have never had invasive cervical cancer.I have never had invasive cervical cancer.My cervix has not been removed.I haven't had a Pap test in the last 3 years or a Pap and HPV test in the last 5 years.My cervix has not been removed.You live in a county located in the Appalachian region.
- Group 1: Group II (usual care continued)
- Group 2: Group I (intervention)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are enrollment opportunities currently available for this research project?
"Correct. Per the information found on clinicaltrials.gov, this research project is presently recruiting participants; it was initially advertised on August 27th 2021 and last updated November 4th 2022."
Does this trial open the door for participants aged 60 and above?
"The parameters of this clinical research call for participants aged 30 to 64. Additionally, there are 29 other studies targeting people younger than 18 and 328 specifically designed for individuals 65 or older."
What is the ideal demographic for partaking in this medical study?
"To qualify for this medical trial, applicants must be aged 30 to 64 and have been diagnosed with human papillomavirus (HPV). This experiment is looking to recruit a total of 2000 participants."
How many individuals are currently involved in this investigational research?
"This medical study mandates 2000 participants that meet the specified criteria. Patients can join this trial from several locations, such as Ohio State University Comprehensive Cancer Center in Columbus, OH and West virginia University in Morgantown, WV."
How widespread is the implementation of this trial?
"Qualified patients may enroll in this trial at Ohio State University Comprehensive Cancer Center, West virginia University or the University of Virginia. Additionally, 4 other sites are available to sign up participants."
Who else is applying?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger